Stock Price
12.35
Daily Change
-0.44 -3.44%
Monthly
-1.04%
Yearly
-2.22%
Q2 Forecast
12.55

Neuren Pharmaceuticals reported AUD0.12 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.





Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Avita Medical AUD -0.38 0 Dec/2025
Clinuvel Pharmaceuticals AUD 0.21 0.23 Dec/2025
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Genetic Signatures AUD -0.03 0.02 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Medical Developments International AUD 0 0 Dec/2025
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organon & Co USD 0.71 0.08 Mar/2026
Paradigm Biopharmaceuticals AUD -0.06 0.03 Dec/2025
PYC Therapeutics AUD -0.04 0.01 Dec/2025
Starpharma Holdings AUD 0 0.01 Dec/2025
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Telix Pharmaceuticals AUD -0.05 0.33 Dec/2025
Viatris USD 0.59 0.02 Mar/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026